首页 > 最新文献

American journal of translational research最新文献

英文 中文
Establishment and validation of a prediction model for successful trial of labor after cesarean in scarred uteruses. 瘢痕子宫剖宫产成功试产预测模型的建立与验证。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/TRPI8982
Xueqin Han, Juhua Ding, Gang Li, Min Su, Dong Yin, Gong Chen, Huiling Liu, Wenli Zhou, Xiaoqiong Li

Objective: To develop and validate a prediction model for successful trial of labor after cesarean (TOLAC) in women with a scarred uterus using clinical data from a single center with an external temporal validation set.

Methods: This retrospective study developed a prediction model using data from a single center (Huai'an Maternal and Child Health Hospital) with scarred uterus planning TOLAC, collected from January 2016 to December 2023. Assessed variables included maternal characteristics, obstetric history, and prenatal examination findings. Univariate and multivariate logistic regression were used to identify predictors and develop the model. The model was temporally validated using an independent external dataset from two other tertiary hospitals. Its performance was evaluated by the area under the ROC curve (AUC), sensitivity, and specificity, and was compared with the Grobman model.

Results: Among 2,386 eligible women, 1,721 (72.1%) had a successful TOLAC. Univariate analysis identified 10 significant variables (P<0.05). Multivariate analysis retained six independent predictors: age, body mass index, history of vaginal delivery, cervical score, estimated fetal weight, and gestational age. The model expression was: Logit(P) = -3.82 + 0.04 × age - 0.12 × BMI + 1.56 × vaginal delivery history + 0.37 × cervical score - 0.02 × fetal weight + 0.18 × gestational age. Internal validation showed an AUC of 0.85 (95% CI: 0.82-0.88), sensitivity of 82.3%, and specificity of 78.5%. Temporal Validation (n=524) yielded an AUC of 0.83 (95% CI: 0.79-0.87), which was significantly higher than the Grobman model (AUC=0.79, P<0.05).

Conclusions: The developed prediction model demonstrates good performance and generalizability for predicting TOLAC success, potentially aiding clinical decision-making and improving maternal and neonatal outcomes.

目的:利用单个中心的临床数据和外部时间验证集,建立并验证疤痕子宫妇女剖宫产后分娩(TOLAC)成功试验的预测模型。方法:本研究采用2016年1月至2023年12月在淮安市妇幼保健院收集的单中心瘢痕子宫计划TOLAC数据,建立预测模型。评估变量包括产妇特征、产科史和产前检查结果。采用单变量和多变量逻辑回归来确定预测因子并建立模型。使用来自另外两家三级医院的独立外部数据集暂时验证了该模型。通过ROC曲线下面积(AUC)、敏感性和特异性评价其性能,并与Grobman模型进行比较。结果:在2386名符合条件的女性中,1721名(72.1%)成功进行了TOLAC。结论:建立的预测模型在预测TOLAC成功方面表现出良好的性能和通用性,可能有助于临床决策和改善孕产妇和新生儿的预后。
{"title":"Establishment and validation of a prediction model for successful trial of labor after cesarean in scarred uteruses.","authors":"Xueqin Han, Juhua Ding, Gang Li, Min Su, Dong Yin, Gong Chen, Huiling Liu, Wenli Zhou, Xiaoqiong Li","doi":"10.62347/TRPI8982","DOIUrl":"https://doi.org/10.62347/TRPI8982","url":null,"abstract":"<p><strong>Objective: </strong>To develop and validate a prediction model for successful trial of labor after cesarean (TOLAC) in women with a scarred uterus using clinical data from a single center with an external temporal validation set.</p><p><strong>Methods: </strong>This retrospective study developed a prediction model using data from a single center (Huai'an Maternal and Child Health Hospital) with scarred uterus planning TOLAC, collected from January 2016 to December 2023. Assessed variables included maternal characteristics, obstetric history, and prenatal examination findings. Univariate and multivariate logistic regression were used to identify predictors and develop the model. The model was temporally validated using an independent external dataset from two other tertiary hospitals. Its performance was evaluated by the area under the ROC curve (AUC), sensitivity, and specificity, and was compared with the Grobman model.</p><p><strong>Results: </strong>Among 2,386 eligible women, 1,721 (72.1%) had a successful TOLAC. Univariate analysis identified 10 significant variables (P<0.05). Multivariate analysis retained six independent predictors: age, body mass index, history of vaginal delivery, cervical score, estimated fetal weight, and gestational age. The model expression was: Logit(P) = -3.82 + 0.04 × age - 0.12 × BMI + 1.56 × vaginal delivery history + 0.37 × cervical score - 0.02 × fetal weight + 0.18 × gestational age. Internal validation showed an AUC of 0.85 (95% CI: 0.82-0.88), sensitivity of 82.3%, and specificity of 78.5%. Temporal Validation (n=524) yielded an AUC of 0.83 (95% CI: 0.79-0.87), which was significantly higher than the Grobman model (AUC=0.79, P<0.05).</p><p><strong>Conclusions: </strong>The developed prediction model demonstrates good performance and generalizability for predicting TOLAC success, potentially aiding clinical decision-making and improving maternal and neonatal outcomes.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"154-166"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embolization of complex cerebral aneurysm at the middle cerebral artery bifurcation using WovenEndoBridge combined with stent (two case reports). WovenEndoBridge联合支架栓塞大脑中动脉分叉处复杂脑动脉瘤(2例报告)。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/LPOD3430
Shu-Juan Zuo, Qing-Liang Chen, Li-Shan Ding, Liu-Tong Zhang, Hao Liang, Ming Zheng, Meng Shen, Zhao-Jun Li, Peng-Chao Zhan, Ji Ma, Teng-Fei Li, Zhi-Guo Li

In recent years, the WovenEndoBridge (WEB), as a representative of emerging intratumoral flow disturbance devices, has been increasingly used in clinical practice. However, there are few reports on how to utilize it correctly when the release position is unsatisfactory or the parent artery is affected during WEB embolization of cerebral aneurysms. We report the treatment process of two female patients who underwent intracranial aneurysm flow diversion therapy for saccular aneurysms at the bifurcation of the middle cerebral artery and benefited from the procedure. The aneurysm embolization was satisfactory during the operation, but the embolization system partially interfered with the parent artery. In order to protect the parent artery and prevent embolism of the Middle Cerebral Artery (MCA) branch, an Atlas stent was introduced to assist in embolization. The angiography was repeated: the parent artery was unobstructed. This article describes in detail the preoperative evaluation of the patient's condition, the surgical plan, and the postoperative treatment. The results of this case confirm the feasibility of stent-assisted WEB embolization of complex aneurysms at the bifurcation of the middle cerebral artery.

近年来,WovenEndoBridge (WEB)作为新兴的肿瘤内血流干扰装置的代表,越来越多地应用于临床。然而,在脑动脉瘤栓塞术中,当释放位置不理想或影响母动脉时,如何正确使用它,鲜有报道。我们报告了两名女性患者在大脑中动脉分叉处接受颅内动脉瘤分流治疗并从中获益的治疗过程。术中动脉瘤栓塞效果良好,但栓塞系统部分干扰了载瘤动脉。为了保护母动脉,防止大脑中动脉(MCA)分支的栓塞,我们引入了Atlas支架来辅助栓塞。重复血管造影:母动脉通畅。本文详细介绍了术前对患者病情的评估、手术方案和术后治疗。本病例的结果证实了支架辅助WEB栓塞治疗大脑中动脉分叉处复杂动脉瘤的可行性。
{"title":"Embolization of complex cerebral aneurysm at the middle cerebral artery bifurcation using WovenEndoBridge combined with stent (two case reports).","authors":"Shu-Juan Zuo, Qing-Liang Chen, Li-Shan Ding, Liu-Tong Zhang, Hao Liang, Ming Zheng, Meng Shen, Zhao-Jun Li, Peng-Chao Zhan, Ji Ma, Teng-Fei Li, Zhi-Guo Li","doi":"10.62347/LPOD3430","DOIUrl":"https://doi.org/10.62347/LPOD3430","url":null,"abstract":"<p><p>In recent years, the WovenEndoBridge (WEB), as a representative of emerging intratumoral flow disturbance devices, has been increasingly used in clinical practice. However, there are few reports on how to utilize it correctly when the release position is unsatisfactory or the parent artery is affected during WEB embolization of cerebral aneurysms. We report the treatment process of two female patients who underwent intracranial aneurysm flow diversion therapy for saccular aneurysms at the bifurcation of the middle cerebral artery and benefited from the procedure. The aneurysm embolization was satisfactory during the operation, but the embolization system partially interfered with the parent artery. In order to protect the parent artery and prevent embolism of the Middle Cerebral Artery (MCA) branch, an Atlas stent was introduced to assist in embolization. The angiography was repeated: the parent artery was unobstructed. This article describes in detail the preoperative evaluation of the patient's condition, the surgical plan, and the postoperative treatment. The results of this case confirm the feasibility of stent-assisted WEB embolization of complex aneurysms at the bifurcation of the middle cerebral artery.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"618-625"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasonographic features and inflammatory status associated with tumor size in breast invasive ductal carcinoma. 乳腺浸润性导管癌的超声特征及炎症状态与肿瘤大小的关系。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/AVFQ2609
Xiao-Hong Liu, Mei-Zhen Fan, Lin Lin, Ying-Ying Bai, Miao Zhang

Objectives: This study explored how ultrasound features relate to tumor size and inflammatory markers in invasive ductal carcinoma (IDC) patients.

Methods: We retrospectively reviewed 218 female IDC patients. Based on the largest diameter of the tumor, patients were split into two groups: those with tumors ≤ 2 cm and those with tumors > 2 cm. We gathered data from conventional ultrasound (CUS), contrast-enhanced ultrasound (CEUS), and virtual touch tissue imaging quantification (VTIQ), along with blood-based inflammation indicators like neutrophil count and C-reactive protein (CRP) levels. Group comparisons were done using univariate analysis, and Spearman correlation was used to examine relationships between tumor size and other variables.

Results: Larger tumors were more frequently located in the upper outer quadrant (60.71% vs 41.03%, P = 0.035) and showed richer blood flow (73.57% vs 53.85%, P = 0.003). By CEUS, larger tumors were more likely to show high enhancement (90% vs 78.21%, P = 0.017) and expanded enhancement range (82.86% vs 70.51%, P = 0.034). VTIQ results showed that SWV max (P = 0.033), SWV peritumoral average (peri-avg) (P = 0.010), and SWVR max/min (P = 0.009) were significantly increased in the larger tumor group. Correlation analysis showed that tumor size was significantly correlated with the above elastic parameters (P < 0.05). For inflammation, CRP was significantly increased in the larger tumor group (P < 0.001) and positively correlated with tumor size (r = 0.249, P = 0.0002); neutrophils were also correlated with SWV peri-avg (r = 0.158, P = 0.019) (P < 0.05).

Conclusions: Tumor size in IDC patients is not only related to their ultrasonographic features but also reflects their inflammatory status.

目的:探讨浸润性导管癌(invasive ductal carcinoma, IDC)患者的超声特征与肿瘤大小和炎症标志物的关系。方法:对218例女性IDC患者进行回顾性分析。根据肿瘤的最大直径将患者分为两组:肿瘤≤2cm组和肿瘤> 2cm组。我们收集了常规超声(CUS)、对比增强超声(CEUS)和虚拟触摸组织成像量化(VTIQ)的数据,以及基于血液的炎症指标,如中性粒细胞计数和c反应蛋白(CRP)水平。使用单变量分析进行组间比较,并使用Spearman相关来检查肿瘤大小与其他变量之间的关系。结果:较大的肿瘤多位于上外象限(60.71% vs 41.03%, P = 0.035),血流丰富(73.57% vs 53.85%, P = 0.003)。超声造影显示,较大的肿瘤更容易表现为高增强(90% vs 78.21%, P = 0.017)和扩大增强范围(82.86% vs 70.51%, P = 0.034)。VTIQ结果显示,较大肿瘤组SWV max (P = 0.033)、SWV瘤周平均值(periavg) (P = 0.010)和SWVR max/min (P = 0.009)均显著升高。相关分析显示,肿瘤大小与上述弹性参数有显著相关(P < 0.05)。对于炎症反应,较大肿瘤组CRP显著升高(P < 0.001),且与肿瘤大小呈正相关(r = 0.249, P = 0.0002);嗜中性粒细胞也与SWV外周血-avg相关(r = 0.158, P = 0.019) (P < 0.05)。结论:IDC患者的肿瘤大小不仅与其超声表现有关,还反映了其炎症状况。
{"title":"Ultrasonographic features and inflammatory status associated with tumor size in breast invasive ductal carcinoma.","authors":"Xiao-Hong Liu, Mei-Zhen Fan, Lin Lin, Ying-Ying Bai, Miao Zhang","doi":"10.62347/AVFQ2609","DOIUrl":"https://doi.org/10.62347/AVFQ2609","url":null,"abstract":"<p><strong>Objectives: </strong>This study explored how ultrasound features relate to tumor size and inflammatory markers in invasive ductal carcinoma (IDC) patients.</p><p><strong>Methods: </strong>We retrospectively reviewed 218 female IDC patients. Based on the largest diameter of the tumor, patients were split into two groups: those with tumors ≤ 2 cm and those with tumors > 2 cm. We gathered data from conventional ultrasound (CUS), contrast-enhanced ultrasound (CEUS), and virtual touch tissue imaging quantification (VTIQ), along with blood-based inflammation indicators like neutrophil count and C-reactive protein (CRP) levels. Group comparisons were done using univariate analysis, and Spearman correlation was used to examine relationships between tumor size and other variables.</p><p><strong>Results: </strong>Larger tumors were more frequently located in the upper outer quadrant (60.71% vs 41.03%, P = 0.035) and showed richer blood flow (73.57% vs 53.85%, P = 0.003). By CEUS, larger tumors were more likely to show high enhancement (90% vs 78.21%, P = 0.017) and expanded enhancement range (82.86% vs 70.51%, P = 0.034). VTIQ results showed that SWV max (P = 0.033), SWV peritumoral average (peri-avg) (P = 0.010), and SWVR max/min (P = 0.009) were significantly increased in the larger tumor group. Correlation analysis showed that tumor size was significantly correlated with the above elastic parameters (P < 0.05). For inflammation, CRP was significantly increased in the larger tumor group (P < 0.001) and positively correlated with tumor size (r = 0.249, P = 0.0002); neutrophils were also correlated with SWV peri-avg (r = 0.158, P = 0.019) (P < 0.05).</p><p><strong>Conclusions: </strong>Tumor size in IDC patients is not only related to their ultrasonographic features but also reflects their inflammatory status.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"207-221"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ulinastatin-somatostatin combination for acute severe pancreatitis: enhanced clinical efficacy and reduced serum inflammation. 乌司他丁-生长抑素联合治疗急性重症胰腺炎:提高临床疗效,降低血清炎症。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/PICX6135
Zirong Liu, Yan Li, Keran Duan, Hao Chi, Yunfeng Cui

Objective: To analyze the clinical effect of ulinastatin (UTI)-somatostatin (SS) combination on acute severe pancreatitis (SAP) patients, focusing on changes in efficacy and serum inflammatory markers (IMs).

Methods: This study retrospectively enrolled 104 SAP patients (July 2022-July 2025), with 51 patients (control group) treated with SS and 53 cases (observation group) receiving UTI+SS. Clinical efficacy, safety (rash, dizziness, diarrhea, nausea/vomiting, kidney injury, hyperglycemia), symptom relief time (vomiting, pyrexia, celialgia, defecation recovery, abdominal distension), disease-related indicators (blood amylase [AMS], Acute Physiology And Chronic Health Evaluation II [APACHE-II]), pancreatic function (insulin [INS], trypsinogen-2 [TPS2], glucose [Glu]), serum IMs (C-reactive protein [CRP], tumor necrosis factor [TNF]-α, interleukin [IL]-6), intestinal mucosal barrier function (diamine oxidase [DAO], D-lactic acid [D-Lac], endotoxin [ET]), laboratory-related indexes (total white blood cell count [WBC], platelet count [PLT], creatinine [Cr], total bilirubin [TBIL]), and humoral immunity (immunoglobulin [Ig] A/M/G) were comparatively assessed. Finally, determinants of patients' therapeutic effects were isolated by uni- and multivariate analyses.

Results: UTI+SS was markedly superior to sole SS in terms of overall effectiveness, INS, PLT, and IgA/M/G, along with faster symptom relief, lower AMS, APACHE-II scores, TPS2, Glu, CRP, TNF-α, IL-6, DAO, D-Lac, WBC, Cr, and TBIL. Total adverse reaction incidence showed no notable inter-group difference. CRP and Cr were independent risk factors for therapeutic efficacy among SAP patients, while treatment modality acted as an independent protective factor.

Conclusion: UTI+SS for SAP is effective in clinical efficacy enhancement and serum inflammation suppression.

目的:分析乌司他丁(UTI)-生长抑素(SS)联合治疗急性重症胰腺炎(SAP)的临床效果,重点观察其疗效及血清炎症标志物(IMs)的变化。方法:本研究回顾性纳入104例SAP患者(2022年7月- 2025年7月),其中51例患者(对照组)接受SS治疗,53例患者(观察组)接受UTI+SS治疗。临床疗效、安全性(皮疹、头晕、腹泻、恶心/呕吐、肾损伤、高血糖)、症状缓解时间(呕吐、发热、乳脂痛、排就恢复、腹胀)、疾病相关指标(血淀粉酶[AMS]、急性生理与慢性健康评估II [APACHE-II])、胰腺功能(胰岛素[INS]、胰蛋白酶原-2 [TPS2]、葡萄糖[Glu])、血清IMs (c反应蛋白[CRP]、肿瘤坏死因子[TNF]-α、白细胞介素[IL]-6)、比较评价肠黏膜屏障功能(二胺氧化酶[DAO]、d -乳酸[D-Lac]、内毒素[ET])、实验室相关指标(白细胞总数[WBC]、血小板总数[PLT]、肌酐[Cr]、总胆红素[TBIL])、体液免疫(免疫球蛋白[Ig] A/M/G)。最后,通过单因素和多因素分析分离患者治疗效果的决定因素。结果:UTI+SS在总疗效、INS、PLT和IgA/M/G方面明显优于单纯SS,症状缓解更快,AMS、APACHE-II评分、TPS2、Glu、CRP、TNF-α、IL-6、DAO、D-Lac、WBC、Cr和TBIL均较低。总不良反应发生率组间差异无统计学意义。CRP和Cr是影响SAP患者疗效的独立危险因素,而治疗方式是影响SAP患者疗效的独立保护因素。结论:UTI+SS治疗SAP可有效提高临床疗效,抑制血清炎症反应。
{"title":"Ulinastatin-somatostatin combination for acute severe pancreatitis: enhanced clinical efficacy and reduced serum inflammation.","authors":"Zirong Liu, Yan Li, Keran Duan, Hao Chi, Yunfeng Cui","doi":"10.62347/PICX6135","DOIUrl":"https://doi.org/10.62347/PICX6135","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the clinical effect of ulinastatin (UTI)-somatostatin (SS) combination on acute severe pancreatitis (SAP) patients, focusing on changes in efficacy and serum inflammatory markers (IMs).</p><p><strong>Methods: </strong>This study retrospectively enrolled 104 SAP patients (July 2022-July 2025), with 51 patients (control group) treated with SS and 53 cases (observation group) receiving UTI+SS. Clinical efficacy, safety (rash, dizziness, diarrhea, nausea/vomiting, kidney injury, hyperglycemia), symptom relief time (vomiting, pyrexia, celialgia, defecation recovery, abdominal distension), disease-related indicators (blood amylase [AMS], Acute Physiology And Chronic Health Evaluation II [APACHE-II]), pancreatic function (insulin [INS], trypsinogen-2 [TPS2], glucose [Glu]), serum IMs (C-reactive protein [CRP], tumor necrosis factor [TNF]-α, interleukin [IL]-6), intestinal mucosal barrier function (diamine oxidase [DAO], D-lactic acid [D-Lac], endotoxin [ET]), laboratory-related indexes (total white blood cell count [WBC], platelet count [PLT], creatinine [Cr], total bilirubin [TBIL]), and humoral immunity (immunoglobulin [Ig] A/M/G) were comparatively assessed. Finally, determinants of patients' therapeutic effects were isolated by uni- and multivariate analyses.</p><p><strong>Results: </strong>UTI+SS was markedly superior to sole SS in terms of overall effectiveness, INS, PLT, and IgA/M/G, along with faster symptom relief, lower AMS, APACHE-II scores, TPS2, Glu, CRP, TNF-α, IL-6, DAO, D-Lac, WBC, Cr, and TBIL. Total adverse reaction incidence showed no notable inter-group difference. CRP and Cr were independent risk factors for therapeutic efficacy among SAP patients, while treatment modality acted as an independent protective factor.</p><p><strong>Conclusion: </strong>UTI+SS for SAP is effective in clinical efficacy enhancement and serum inflammation suppression.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"583-595"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticancer effects of black ginseng extract on human gastric cancer in a xenograft mouse model. 黑参提取物对人胃癌异种移植小鼠模型的抗癌作用。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/NSFW4096
Hye Jin Park, Ha Rin Namkung, Su Bin Jung, Kwang-Tae Choi, Seung Tae Lee

Objective: This study investigated the potential of black ginseng extract (BGE) to prevent and treat gastric cancer by evaluating its effects on the proliferation of human gastric cancer cells and the growth of human gastric tumors implanted in mice.

Materials and methods: The antitumor effects of BGE on gastric cancer were evaluated by assessing its cytotoxicity and apoptotic activity in AGS and KATO III gastric cancer cells. Additionally, in a nude mouse model with AGS cell xenografts, tumor volume, weight, size, and body weight were analyzed following oral administration of BGE, red ginseng extract (RGE), or no treatment. Subsequently, the liver and spleen were weighed, and histopathological analysis was performed to assess the non-toxicity of BGE to non-cancerous cells.

Results: In vitro studies revealed that BGE had significant cytotoxic and apoptotic effects on AGS and KATO III gastric cancer cells. In vivo, oral administration of RGE and BGE to nude mice with AGS cell xenografts resulted in no increase in tumor volume or body weight, while both tumor weight and size were significantly reduced. Notably, the group treated with BGE had significantly smaller tumors and weight than the RGE-treated group. Furthermore, following oral BGE, no significant differences were observed in the weights of the liver and spleen, and no histopathological abnormalities were detected in the organs of the AGS cell xenograft mice.

Conclusions: BGE exhibited anticancer activity against gastric cancer cells in vitro and in vivo, with no toxicity observed in the major organs.

目的:通过观察黑参提取物对人胃癌细胞增殖和人胃癌肿瘤植入小鼠体内生长的影响,探讨黑参提取物对胃癌的防治作用。材料与方法:通过对AGS和KATO III型胃癌细胞的细胞毒性和凋亡活性评价BGE对胃癌的抗肿瘤作用。此外,在异种移植AGS细胞的裸鼠模型中,对口服BGE、红参提取物(RGE)或不给药的肿瘤体积、重量、大小和体重进行分析。随后,称重肝脏和脾脏,并进行组织病理学分析,以评估BGE对非癌细胞的无毒性。结果:体外实验表明,BGE对AGS和KATO III型胃癌细胞具有明显的细胞毒和凋亡作用。在体内,对异种移植AGS细胞的裸鼠口服RGE和BGE,肿瘤体积和体重均未增加,但肿瘤重量和大小均明显减小。值得注意的是,BGE治疗组的肿瘤和体重明显小于rge治疗组。此外,口服BGE后,AGS细胞异种移植小鼠的肝脏和脾脏重量无显著差异,脏器未见组织病理学异常。结论:BGE在体外和体内均对胃癌细胞具有抗肿瘤活性,对主要脏器无毒性作用。
{"title":"Anticancer effects of black ginseng extract on human gastric cancer in a xenograft mouse model.","authors":"Hye Jin Park, Ha Rin Namkung, Su Bin Jung, Kwang-Tae Choi, Seung Tae Lee","doi":"10.62347/NSFW4096","DOIUrl":"https://doi.org/10.62347/NSFW4096","url":null,"abstract":"<p><strong>Objective: </strong>This study investigated the potential of black ginseng extract (BGE) to prevent and treat gastric cancer by evaluating its effects on the proliferation of human gastric cancer cells and the growth of human gastric tumors implanted in mice.</p><p><strong>Materials and methods: </strong>The antitumor effects of BGE on gastric cancer were evaluated by assessing its cytotoxicity and apoptotic activity in AGS and KATO III gastric cancer cells. Additionally, in a nude mouse model with AGS cell xenografts, tumor volume, weight, size, and body weight were analyzed following oral administration of BGE, red ginseng extract (RGE), or no treatment. Subsequently, the liver and spleen were weighed, and histopathological analysis was performed to assess the non-toxicity of BGE to non-cancerous cells.</p><p><strong>Results: </strong><i>In vitro</i> studies revealed that BGE had significant cytotoxic and apoptotic effects on AGS and KATO III gastric cancer cells. <i>In vivo</i>, oral administration of RGE and BGE to nude mice with AGS cell xenografts resulted in no increase in tumor volume or body weight, while both tumor weight and size were significantly reduced. Notably, the group treated with BGE had significantly smaller tumors and weight than the RGE-treated group. Furthermore, following oral BGE, no significant differences were observed in the weights of the liver and spleen, and no histopathological abnormalities were detected in the organs of the AGS cell xenograft mice.</p><p><strong>Conclusions: </strong>BGE exhibited anticancer activity against gastric cancer cells in vitro and in vivo, with no toxicity observed in the major organs.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"751-758"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal optical coherence tomography and angiography and serologic markers for accurate early diagnosis of dysthyroid optic neuropathy. 多模态光学相干断层扫描、血管造影及血清学指标对甲状腺功能障碍视神经病变的准确早期诊断。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/SDKT8956
Yusheng Zhao, Qian Xiao, Bin Fan, Lu Tang, Xiaohu Chen, Yan Dai

Objective: To assess the value of optical coherence tomography (OCT) and OCT angiography (OCTA) for the early diagnosis of dysthyroid optic neuropathy (DON) in patients with thyroid-associated orbitopathy (TAO).

Methods: This retrospective study (2022-2024) included 52 TAO eyes (22 DON, 30 non-DON) and 52 healthy controls. OCT/OCTA scans evaluated structural features (ganglion cell complex, peripapillary retinal nerve fiber layer, Bruch's membrane opening-minimum rim width [BMO-MRW]) and vascular features (superficial retinal capillary plexus [SRCP] density, choroidal capillary vascular density, foveal avascular zone [FAZ] area). Contrast sensitivity function (CSF), thyroid peroxidase antibody (TPOAb) status, and glutamate levels were also analyzed. Multivariate logistic regression identified risk factors, and receiver operating characteristic curves evaluated diagnostic performance.

Results: Most structural OCT features showed no significant differences, except CSF, which was significantly reduced in DON eyes (P < 0.001). Vascular features such as SRCP density and choroidal capillary density decreased progressively in DON, while FAZ area was significantly larger (all P < 0.001). TPOAb positivity and glutamate levels were highest in the DON group (P < 0.001). Multivariate analysis identified SRCP density, FAZ area, TPOAb positivity, and glutamate concentration as independent risk factors for DON. A combined model of BMO-MRW and subfoveal choroidal thickness achieved the highest diagnostic accuracy (AUC = 0.940, sensitivity = 88.0%, specificity = 90.0%).

Conclusions: Multimodal imaging combining OCT and OCTA features improves the sensitivity and specificity of early DON diagnosis, offering a reliable, noninvasive screening approach for clinical practice.

目的:探讨光学相干断层扫描(OCT)和OCT血管造影(OCTA)对甲状腺相关性眼病(TAO)患者甲状腺功能不全视神经病变(DON)的早期诊断价值。方法:回顾性研究(2022-2024)包括52只TAO眼(DON 22只,non-DON 30只)和52名健康对照。OCT/OCTA扫描评估结构特征(神经节细胞复群、乳头周围视网膜神经纤维层、Bruch膜开口-最小边缘宽度[BMO-MRW])和血管特征(视网膜浅毛细血管丛[SRCP]密度、脉络膜毛细血管密度、中央凹无血管区[FAZ]面积)。对比敏感功能(CSF)、甲状腺过氧化物酶抗体(TPOAb)状态和谷氨酸水平也进行了分析。多变量逻辑回归确定危险因素,并使用受试者工作特征曲线评估诊断效果。结果:除脑脊液(CSF)在DON眼中显著降低外,其余大部分OCT结构特征无显著差异(P < 0.001)。DON患者SRCP密度、脉络膜毛细血管密度逐渐降低,FAZ面积明显增大(均P < 0.001)。DON组TPOAb阳性和谷氨酸水平最高(P < 0.001)。多因素分析发现SRCP密度、FAZ面积、TPOAb阳性和谷氨酸浓度是DON的独立危险因素。BMO-MRW和中央凹下脉络膜厚度联合模型的诊断准确率最高(AUC = 0.940,灵敏度= 88.0%,特异性= 90.0%)。结论:结合OCT和OCTA特征的多模态成像提高了早期DON诊断的敏感性和特异性,为临床提供了可靠的、无创的筛查方法。
{"title":"Multimodal optical coherence tomography and angiography and serologic markers for accurate early diagnosis of dysthyroid optic neuropathy.","authors":"Yusheng Zhao, Qian Xiao, Bin Fan, Lu Tang, Xiaohu Chen, Yan Dai","doi":"10.62347/SDKT8956","DOIUrl":"https://doi.org/10.62347/SDKT8956","url":null,"abstract":"<p><strong>Objective: </strong>To assess the value of optical coherence tomography (OCT) and OCT angiography (OCTA) for the early diagnosis of dysthyroid optic neuropathy (DON) in patients with thyroid-associated orbitopathy (TAO).</p><p><strong>Methods: </strong>This retrospective study (2022-2024) included 52 TAO eyes (22 DON, 30 non-DON) and 52 healthy controls. OCT/OCTA scans evaluated structural features (ganglion cell complex, peripapillary retinal nerve fiber layer, Bruch's membrane opening-minimum rim width [BMO-MRW]) and vascular features (superficial retinal capillary plexus [SRCP] density, choroidal capillary vascular density, foveal avascular zone [FAZ] area). Contrast sensitivity function (CSF), thyroid peroxidase antibody (TPOAb) status, and glutamate levels were also analyzed. Multivariate logistic regression identified risk factors, and receiver operating characteristic curves evaluated diagnostic performance.</p><p><strong>Results: </strong>Most structural OCT features showed no significant differences, except CSF, which was significantly reduced in DON eyes (P < 0.001). Vascular features such as SRCP density and choroidal capillary density decreased progressively in DON, while FAZ area was significantly larger (all P < 0.001). TPOAb positivity and glutamate levels were highest in the DON group (P < 0.001). Multivariate analysis identified SRCP density, FAZ area, TPOAb positivity, and glutamate concentration as independent risk factors for DON. A combined model of BMO-MRW and subfoveal choroidal thickness achieved the highest diagnostic accuracy (AUC = 0.940, sensitivity = 88.0%, specificity = 90.0%).</p><p><strong>Conclusions: </strong>Multimodal imaging combining OCT and OCTA features improves the sensitivity and specificity of early DON diagnosis, offering a reliable, noninvasive screening approach for clinical practice.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"676-690"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing sedation in elderly patients: advantages and challenges of alfentanil-ciprofol for painless gastroscopy. 优化老年患者镇静:阿芬太尼-环丙酚用于无痛胃镜检查的优势和挑战。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/VEKM9101
Xiaoyun Zhang, Haixia Wei, Jing Xia, Yongxin Liang

The trend of painless diagnostic and therapeutic procedures is on the increase among older patients as the global population is aging. The pathophysiological changes unique to the aging process are troublesome in terms of sedation management. The use of the traditional narcotic sedation guidelines like fentanyl and propofol is linked to respiratory and circulatory suppression in this at-risk group. Conversely, the new compound of alfentanil-ciprofol has shown potential pharmacological benefits that can maximize sedation in painless gastroscopy in the elderly. This is a systematic literature review discussing the physiological and pharmacological basis for sedation in older individuals, with a focus on the interactions and efficacy of alfentanil and ciprofol. By synthesizing the available evidence, we generalize upon the effectiveness, safety, quality of recovery and benefits of such a combination on the geriatric gastroscopy procedure. Furthermore, we address the challenges inherent to its use in this age group, such as dose individualization and respiratory management, and propose potential solutions. Lastly, we outline future research directions, emphasizing that individualized dosing strategies based on the principles of precision anesthesia will be central to optimizing outcomes for elderly patients.

随着全球人口老龄化,在老年患者中,无痛诊断和治疗程序的趋势正在增加。衰老过程中独特的病理生理变化在镇静管理方面是麻烦的。在这一高危人群中,使用芬太尼和异丙酚等传统麻醉镇静指南与呼吸和循环抑制有关。相反,新化合物阿芬太尼-环丙酚显示出潜在的药理作用,可以最大限度地镇静老年人的无痛胃镜检查。这是一篇系统的文献综述,讨论了老年人镇静的生理和药理学基础,重点是阿芬太尼和环丙酚的相互作用和疗效。通过综合现有的证据,我们总结了这种组合在老年胃镜手术中的有效性、安全性、恢复质量和益处。此外,我们解决了在这个年龄组使用它所固有的挑战,如剂量个性化和呼吸管理,并提出了潜在的解决方案。最后,我们概述了未来的研究方向,强调基于精确麻醉原则的个体化给药策略将是优化老年患者预后的核心。
{"title":"Optimizing sedation in elderly patients: advantages and challenges of alfentanil-ciprofol for painless gastroscopy.","authors":"Xiaoyun Zhang, Haixia Wei, Jing Xia, Yongxin Liang","doi":"10.62347/VEKM9101","DOIUrl":"https://doi.org/10.62347/VEKM9101","url":null,"abstract":"<p><p>The trend of painless diagnostic and therapeutic procedures is on the increase among older patients as the global population is aging. The pathophysiological changes unique to the aging process are troublesome in terms of sedation management. The use of the traditional narcotic sedation guidelines like fentanyl and propofol is linked to respiratory and circulatory suppression in this at-risk group. Conversely, the new compound of alfentanil-ciprofol has shown potential pharmacological benefits that can maximize sedation in painless gastroscopy in the elderly. This is a systematic literature review discussing the physiological and pharmacological basis for sedation in older individuals, with a focus on the interactions and efficacy of alfentanil and ciprofol. By synthesizing the available evidence, we generalize upon the effectiveness, safety, quality of recovery and benefits of such a combination on the geriatric gastroscopy procedure. Furthermore, we address the challenges inherent to its use in this age group, such as dose individualization and respiratory management, and propose potential solutions. Lastly, we outline future research directions, emphasizing that individualized dosing strategies based on the principles of precision anesthesia will be central to optimizing outcomes for elderly patients.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"51-63"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of the combined application of oxidative stress indicators and carcinoembryonic antigen for patients with early lung adenocarcinoma. 氧化应激指标与癌胚抗原联合应用对早期肺腺癌患者的预测价值。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/ZWFW6679
Lu Xu, Chenlin Lu, Tianyu Chen, Bing Zhang

Objectives: To explore the expression levels of oxidative stress indicators and carcinoembryonic antigen (CEA) in different pathologic types of pulmonary ground-glass nodules (GGN) and their predictive value for early lung adenocarcinoma.

Methods: This study was a retrospective analysis. General data were collected from 100 patients diagnosed in The Affiliated Taizhou People's Hospital of Nanjing Medical University from February 2022 to May 2024 with GGN in the lungs. According to pathologic types, they were divided into the glandular prodromal lesion group (n=39) and the lung adenocarcinoma group (n=61). The pretreatment levels of CEA, reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) were compared between the two groups. Risk factors for developing early-stage lung adenocarcinoma were screened by univariate versus multivariate logistic regression analysis. The receiver operator characteristic curve (ROC) was used to evaluate the predictive value of each index for early lung adenocarcinoma.

Results: Compared to the glandular prodromal lesion group, the levels of ROS, MDA and CEA in the lung adenocarcinoma group were significantly higher, while the level of SOD was significantly lower (P<0.05). Multifactorial logistic regression analysis showed that high MDA (OR=7.205, 95% CI: 1.587-32.704), high ROS (OR=3.553, 95% CI: 1.552-8.136), and high CEA (OR=3.241, 95% CI: 1.343-7.818) were risk factors for developing early-stage lung adenocarcinoma (all P<0.05) while elevated SOD levels were a protective factor (OR=0.513, 95% CI: 0.328-0.803, P<0.05). ROC curve analysis showed that the combined application of tests had the highest predictive efficacy, with an area under the curve (AUC) of 0.887, both higher than those of the single tests.

Conclusions: Oxidative stress indicators and CEA show regular changes in GGN. Combined detection can significantly improve the predictive ability for early lung adenocarcinoma.

目的:探讨氧化应激指标和癌胚抗原(CEA)在不同病理类型肺磨玻璃结节(GGN)中的表达水平及其对早期肺腺癌的预测价值。方法:采用回顾性分析方法。收集南京医科大学附属台州人民医院2022年2月至2024年5月诊断为肺GGN的100例患者的一般资料。根据病理类型分为腺前病变组(n=39)和肺腺癌组(n=61)。比较两组治疗前CEA、活性氧(ROS)、超氧化物歧化酶(SOD)、丙二醛(MDA)水平。通过单因素和多因素logistic回归分析筛选早期肺腺癌的危险因素。采用受试者特征曲线(receiver operator characteristic curve, ROC)评价各指标对早期肺腺癌的预测价值。结果:与腺体前驱病变组相比,肺腺癌组ROS、MDA、CEA水平显著升高,SOD水平显著降低(p)。结论:氧化应激指标和CEA在GGN中呈规律性变化。联合检测可显著提高早期肺腺癌的预测能力。
{"title":"Predictive value of the combined application of oxidative stress indicators and carcinoembryonic antigen for patients with early lung adenocarcinoma.","authors":"Lu Xu, Chenlin Lu, Tianyu Chen, Bing Zhang","doi":"10.62347/ZWFW6679","DOIUrl":"https://doi.org/10.62347/ZWFW6679","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the expression levels of oxidative stress indicators and carcinoembryonic antigen (CEA) in different pathologic types of pulmonary ground-glass nodules (GGN) and their predictive value for early lung adenocarcinoma.</p><p><strong>Methods: </strong>This study was a retrospective analysis. General data were collected from 100 patients diagnosed in The Affiliated Taizhou People's Hospital of Nanjing Medical University from February 2022 to May 2024 with GGN in the lungs. According to pathologic types, they were divided into the glandular prodromal lesion group (n=39) and the lung adenocarcinoma group (n=61). The pretreatment levels of CEA, reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) were compared between the two groups. Risk factors for developing early-stage lung adenocarcinoma were screened by univariate versus multivariate logistic regression analysis. The receiver operator characteristic curve (ROC) was used to evaluate the predictive value of each index for early lung adenocarcinoma.</p><p><strong>Results: </strong>Compared to the glandular prodromal lesion group, the levels of ROS, MDA and CEA in the lung adenocarcinoma group were significantly higher, while the level of SOD was significantly lower (P<0.05). Multifactorial logistic regression analysis showed that high MDA (OR=7.205, 95% CI: 1.587-32.704), high ROS (OR=3.553, 95% CI: 1.552-8.136), and high CEA (OR=3.241, 95% CI: 1.343-7.818) were risk factors for developing early-stage lung adenocarcinoma (all P<0.05) while elevated SOD levels were a protective factor (OR=0.513, 95% CI: 0.328-0.803, P<0.05). ROC curve analysis showed that the combined application of tests had the highest predictive efficacy, with an area under the curve (AUC) of 0.887, both higher than those of the single tests.</p><p><strong>Conclusions: </strong>Oxidative stress indicators and CEA show regular changes in GGN. Combined detection can significantly improve the predictive ability for early lung adenocarcinoma.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"455-461"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative hemoglobin, albumin, lymphocyte, and platelet (HALP) score for predictive utility in patients undergoing elective supratentorial craniotomy. 术前血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分对选择性幕上开颅患者的预测价值。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/QNOW9674
Lina Zhang, Li Qiao, Hongxun Yuan

Background: Elective supratentorial craniotomies may affect short-term prognoses. This study investigates the utility of the preoperative Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score for predicting patient outcomes following such procedures.

Methods: We retrospectively analyzed patients who underwent elective supratentorial craniotomy at a single center between January 2018 and August 2022. Outcomes were categorized as favorable or unfavorable according to survival and the occurrence of major complications. The HALP score was calculated from preoperative blood samples collected within 24 hours before surgery. Postoperative evaluation encompassed monitoring of complications, cognitive function using the Montreal Cognitive Assessment (MoCA), and neurological status assessed with the Glasgow Coma Scale (GCS).

Results: After propensity score matching, 150 patients were analyzed (75 per group). Preoperative HALP scores in the good prognosis group were significantly higher than those of the poor prognosis group (73.24 ± 8.45 vs. 61.67 ± 7.82, P < 0.001). Multivariate analysis confirmed that lower values of HALP components independently increased the risk of poor prognosis. The receiver operator characteristic (ROC) analysis showed that the HALP score (AUC = 0.841) was better as a predictor of poor prognosis than its component alone, with an optimal intersection value of 69.42 (sensitivity = 0.84, specificity = 0.747). Patients with a low HALP score also experienced less than ideal perioperative outcomes, including longer surgery times, more blood loss, longer hospital stays, and higher rates of neurological dysfunction, consciousness disorders, and infections.

Conclusions: Preoperative HALP score can predict the short-term outcome of patients undergoing elective supratentorial neurosurgery.

背景:选择性幕上开颅术可能影响短期预后。本研究探讨了术前血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分在预测此类手术后患者预后方面的作用。方法:回顾性分析2018年1月至2022年8月在单一中心接受选择性幕上开颅手术的患者。结果根据生存和主要并发症的发生分为有利或不利。根据术前24小时内采集的血液样本计算HALP评分。术后评估包括监测并发症,使用蒙特利尔认知评估(MoCA)评估认知功能,并使用格拉斯哥昏迷量表(GCS)评估神经状态。结果:倾向评分匹配后,分析150例患者(每组75例)。预后良好组术前HALP评分明显高于预后差组(73.24±8.45比61.67±7.82,P < 0.001)。多因素分析证实,较低的HALP成分值单独增加了预后不良的风险。受试者操作特征(receiver operator characteristic, ROC)分析显示,HALP评分(AUC = 0.841)作为不良预后的预测指标优于其单独分量,最佳交叉值为69.42(敏感性= 0.84,特异性= 0.747)。HALP评分较低的患者围手术期预后也不理想,包括手术时间较长、失血较多、住院时间较长、神经功能障碍、意识障碍和感染发生率较高。结论:术前HALP评分可以预测选择性幕上神经外科手术患者的短期预后。
{"title":"Preoperative hemoglobin, albumin, lymphocyte, and platelet (HALP) score for predictive utility in patients undergoing elective supratentorial craniotomy.","authors":"Lina Zhang, Li Qiao, Hongxun Yuan","doi":"10.62347/QNOW9674","DOIUrl":"https://doi.org/10.62347/QNOW9674","url":null,"abstract":"<p><strong>Background: </strong>Elective supratentorial craniotomies may affect short-term prognoses. This study investigates the utility of the preoperative Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score for predicting patient outcomes following such procedures.</p><p><strong>Methods: </strong>We retrospectively analyzed patients who underwent elective supratentorial craniotomy at a single center between January 2018 and August 2022. Outcomes were categorized as favorable or unfavorable according to survival and the occurrence of major complications. The HALP score was calculated from preoperative blood samples collected within 24 hours before surgery. Postoperative evaluation encompassed monitoring of complications, cognitive function using the Montreal Cognitive Assessment (MoCA), and neurological status assessed with the Glasgow Coma Scale (GCS).</p><p><strong>Results: </strong>After propensity score matching, 150 patients were analyzed (75 per group). Preoperative HALP scores in the good prognosis group were significantly higher than those of the poor prognosis group (73.24 ± 8.45 vs. 61.67 ± 7.82, <i>P</i> < 0.001). Multivariate analysis confirmed that lower values of HALP components independently increased the risk of poor prognosis. The receiver operator characteristic (ROC) analysis showed that the HALP score (AUC = 0.841) was better as a predictor of poor prognosis than its component alone, with an optimal intersection value of 69.42 (sensitivity = 0.84, specificity = 0.747). Patients with a low HALP score also experienced less than ideal perioperative outcomes, including longer surgery times, more blood loss, longer hospital stays, and higher rates of neurological dysfunction, consciousness disorders, and infections.</p><p><strong>Conclusions: </strong>Preoperative HALP score can predict the short-term outcome of patients undergoing elective supratentorial neurosurgery.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"563-573"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viral infections in solid organ transplant recipients: immunological principles and intervention strategies. 实体器官移植受者的病毒感染:免疫学原理和干预策略。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.62347/ZSRU1567
Ziyu Wang, Kaiwen Sheng, Yansen Wang, Jianhua Luo, Meng Guo

Objective: This review aims to examine the challenges of opportunistic viral infections in transplant recipients on long-term immunosuppression and to explore the potential of emerging immunotherapies to improve infection management.

Methods: We summarize the mechanisms and effects of current clinical immunosuppressants, outline the incidence of viral infections following various organ transplants, and discuss the limitations of existing antiviral pharmacotherapies. Furthermore, we systematically review recent advances in novel immunotherapies that harness the patient's immune system.

Results: While immunosuppressive regimens significantly improve graft survival, they increase susceptibility to viral infections. Emerging immunotherapies demonstrate promising potential in managing these infections, yet their application in transplant recipients remains underexplored.

Conclusion: Innovative immunotherapies represent a promising avenue for overcoming the limitations of conventional treatments. Their integration into transplantation practice may enhance long-term outcomes, although further clinical validation is needed.

目的:本综述旨在研究移植受者机会性病毒感染对长期免疫抑制的挑战,并探讨新兴免疫疗法改善感染管理的潜力。方法:总结目前临床免疫抑制剂的作用机制和效果,概述各种器官移植后病毒感染的发生率,并讨论现有抗病毒药物治疗的局限性。此外,我们系统地回顾了利用患者免疫系统的新型免疫疗法的最新进展。结果:虽然免疫抑制方案显著提高移植物存活率,但它们增加了对病毒感染的易感性。新兴的免疫疗法在治疗这些感染方面显示出很大的潜力,但它们在移植受者中的应用仍未得到充分的探索。结论:创新免疫疗法为克服常规治疗的局限性提供了一条有希望的途径。尽管需要进一步的临床验证,但将它们整合到移植实践中可能会提高长期疗效。
{"title":"Viral infections in solid organ transplant recipients: immunological principles and intervention strategies.","authors":"Ziyu Wang, Kaiwen Sheng, Yansen Wang, Jianhua Luo, Meng Guo","doi":"10.62347/ZSRU1567","DOIUrl":"https://doi.org/10.62347/ZSRU1567","url":null,"abstract":"<p><strong>Objective: </strong>This review aims to examine the challenges of opportunistic viral infections in transplant recipients on long-term immunosuppression and to explore the potential of emerging immunotherapies to improve infection management.</p><p><strong>Methods: </strong>We summarize the mechanisms and effects of current clinical immunosuppressants, outline the incidence of viral infections following various organ transplants, and discuss the limitations of existing antiviral pharmacotherapies. Furthermore, we systematically review recent advances in novel immunotherapies that harness the patient's immune system.</p><p><strong>Results: </strong>While immunosuppressive regimens significantly improve graft survival, they increase susceptibility to viral infections. Emerging immunotherapies demonstrate promising potential in managing these infections, yet their application in transplant recipients remains underexplored.</p><p><strong>Conclusion: </strong>Innovative immunotherapies represent a promising avenue for overcoming the limitations of conventional treatments. Their integration into transplantation practice may enhance long-term outcomes, although further clinical validation is needed.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 1","pages":"13-34"},"PeriodicalIF":1.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of translational research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1